Navigation Links
Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
Date:11/6/2008

- Voreloxin Demonstrates Promising Clinical Activity in Patients with

Difficult-to-Treat Cancers -

SOUTH SAN FRANCISCO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) presented data from three clinical trials of the company's lead drug candidate, voreloxin (formerly SNS-595), at the Chemotherapy Foundation Symposium held in New York on November 4-8. Data previously presented from Phase 1 and Phase 1b/2 studies in patients with acute myeloid leukemia (AML) showed that preliminary clinical responses were observed in the relapsed/refractory AML population and the data supports further clinical development for voreloxin both as a single agent and in combination with cytarabine. Preliminary efficacy results previously presented from an ongoing Phase 2 trial demonstrate single agent activity of voreloxin in advanced platinum-resistant ovarian cancer and that the drug is generally well tolerated in this difficult-to-treat patient population.

"We believe that voreloxin has the potential to change the standard of care in AML and platinum-resistant ovarian cancer and look forward to reporting updated results of our AML trials at ASH," said Daniel Swisher, Chief Executive Officer, Sunesis Pharmaceuticals. "Our goal is to advance voreloxin into a pivotal trial in AML by the end of 2009."

Phase 1 and 1b/2 Studies of Voreloxin in AML

Data presented from a completed Phase 1 dose escalation trial of voreloxin as a single agent in acute leukemias (N=73) showed that single agent voreloxin was generally well tolerated, with the most frequently observed dose limited toxicity (DLT) being reversible grade 3/4 oral mucositis. The researchers concluded that single agent a
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
4. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
5. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
7. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
8. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
9. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
10. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
11. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 19, 2013 , ... disease (PD) patients as add-on to levodopa ... in motor symptoms in fluctuating PD patients as ... Newron Pharmaceuticals S.p.A. ("Newron"), a research and development ... and its partner Zambon S.p.A., a pharmaceutical company ...
(Date:6/18/2013)... 2013 /PRNewswire-iReach/ -- Today E-T-A Circuit Breakers announced ... Module. The X3130, integrated with E-T-A,s double-pole ... appliance inlet module, rocker switch and resettable overcurrent ... allows design engineers to streamline the number of ... by 66 percent - and reduce the overall ...
(Date:6/18/2013)... June 18, 2013  Recent regulatory and budget challenges ... Education groups at large pharmaceutical companies to effectively educate ... effective use of their new products. With the pressure ... is crucial that these "Med Ed" groups ... To address the changes that are transforming the ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Three-in-One X3130 Appliance Inlet Module 2Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2
... Dec. 14, 2010 The U.S. Food and Drug Administration ... children younger than 10 years can result in serious ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Tessalon, approved by the FDA ... than 10, may attract younger children because of the ...
... announces that a new market research report is ... Markets for Video, High-Tech and Integrated OT Equipment ... The European Markets for Video, High-Tech ... Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain ...
Cached Medicine Technology:FDA Says Tessalon Liquid Cough Capsules Pose Risk for Young Children 2Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 2Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 3Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 4Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 5Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 6Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 7Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 8Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 9Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 10Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 11Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 12Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 13Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 14Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 15Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 16Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 17Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 18Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 19
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
(Date:6/19/2013)... Alternatives, a revolutionary new treatment facility ... using drugs while allowing them to continue drinking alcohol. ... Alternatives, believe that abstinence-only approaches force people to wait ... that this approach hurts instead of helping. It ... States need treatment for addiction but only 3 million ...
(Date:6/19/2013)... June 19, 2013 Many trying-to-conceive ... it medically necessary, according to a recent ... Health Journal. The results of this research confirm ... than a decade – that trying-to-conceive women would ... a healthy body weight. Fairhaven Health is a ...
(Date:6/19/2013)... UK-- New data, published today in Menopause ... are experiencing less sex, and less satisfying sex ... because they are considerably less likely to access ... vaginal atrophy1. , The first-of-its-kind study, called the ... (CLOSER) study, showed that British post-menopausal women with ...
(Date:6/19/2013)... FL (PRWEB) June 19, 2013 Ultimate ... Children's Telethon, an 11.5-hour broadcast on WFLA News Channel ... has collected more than $84 million for All Children's ... 2013, event, themed "30 Years of Miracles," marked the ... hour, 18 UMA employees worked the phones during the ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3
... 14 Here are,highlights from the July issue ... publication as often as you wish. Reprinting is ... is required. Include the following,subscription information as your ... toll-free for subscription,information, 1-800-333-9037, extension 9PR1., Test ...
... their heads perfectly still while putting may be hampering their ... , The research appears in the July issue of the ... of kinesiology at McMaster University and a golfer himselfsays the ... golf wisdom. , "Jack Nicklaus says the premier technical cause ...
... Physicians Cited Concerns After Delays in Delivering Equipment, ... 14 Florida physicians,have written letters to Sen. ... new Medicare competitive bidding program for durable medical,equipment ... Lauderdale, and,eight other metropolitan areas in the U.S., ...
... 14 The American Heart,Association,s new national officers ... David A. Josserand, executive vice president and chief ... is national chairman of,the board. Josserand will be ... fund raising, and will preside over all Board,of ...
... Widespread ... of Incisionless NOTES Surgery, SAN CLEMENTE, Calif., July ... Horgan, M.D., director of the UC San Diego,Center for ... (EOS) to demonstrate a technique that allows for appendectomy,without ...
... increase in death, major complications , , MONDAY, July ... after heart surgery is essential, whether one is or ... The British report, published in Circulation , ... patients is linked to a fourfold increase in death ...
Cached Medicine News:Health News:July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts 2Health News:July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts 3Health News:July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts 4Health News:When it comes to putting, Tiger and Nicklaus 2Health News:Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge 2Health News:Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge 3Health News:Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge 4Health News:Josserand and Gardner to Lead American Heart Association in 2008-09 2Health News:Surgeons Use USGI Medical's EndoSurgical Operating System to Complete Live Incisionless Appendectomy at Leading NOTES Conference 2Health News:Poor Blood Sugar Control After Heart Surgery Impacts Outcomes 2
... is a combination of a screw and a ... offered by resorbable pins for a hammertoe fixation ... easy to use! Drill and tap the proximal ... portion of the implant proximally. Press fit the ...
The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...
... ideal for excising soft tissue more efficiently than ... The serrated edge on the straight scissor helps ... within the jaws for more efficient resection.,The curved ... are the perfect tools for ACL stump removal, ...
... The Arthroscopy Scissor is ideal for excising soft ... debris in the joint. The serrated edge on ... well as hold tissue within the jaws for ... and right jaw curvatures, are the perfect tools ...
Medicine Products: